Carpal Tunnel Release Through Mini Transverse Approach

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02766114

Acronym

CTRMTA

Enrollment

Registered

2016-05-09

Start date

2013-02-28

Completion date

2016-03-31

Last updated

2016-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Release, Carpal Tunnel Surgery, Carpal Tunnel Syndrome, Carpal Tunnel Transverse Approach, CTS

Keywords

CTS, Carpal tunnel syndrome, Carpal tunnel release, Mini incision of carpal tunnel release, Cosmetic surgery of carpal tunnel syndrome, endoscopic carpal tunnel surgery, Carpal Tunnel Release Through Mini Transverse Approach, Dr. Sayed Issa's Approach, CTRMTA, OCTR, ECTR, Open Carpal Tunnel Release, Endoscopic Carpal Tunnel Release, Syria, Cosmetic, Safety, Rehabilitation,, Complications, Surgery, Satisfaction

Brief summary

Carpal tunnel release through dorsal wrist crease Mini Transverse incision, about 1.5 cm length.

Detailed description

Carpal tunnel release through a small approach on the distal wrist crease, it is about 1.5 cm, the benefits of this technique is less surgical traumatic and more tender, it takes less time for rehabilitation, so the patient can work next day of operation, and it has very cosmetic and gentle scar in results and outcome.

Interventions

PROCEDURECarpal tunnel release through Mini Transverse Approach

Carpal tunnel release through a transverse cosmetic small incision over the distal wrist crease.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

16 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patients presented with Carpal Tunnel Syndrome refractory to conservative treatment * Participant cooperation sufficient to operate under local anesthesia

Exclusion criteria

* Un controlled diabetes mellitus type 1 and 2 * Patients with non controlled Vascular hypertension * Significant renal disease, defined as a history of chronic renal failure requiring dialysis or kidney transplant. * Myocardial infarction, other acute cardiac event requiring hospitalization, stroke, transient ischemic attack, or treatment for acute congestive heart failure within 4 months prior to randomization * Patients with history of Carpal Tunnel release surgery failure

Design outcomes

Primary

Measure	Time frame
Proportion of patients with post surgical trauma	Up to eight weeks

Secondary

Measure	Time frame
Duration of rehabilitation period	Up to three weeks
Proportion of patients with cosmetic scar	Up to 6 months

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026